APA (7th ed.) Citation

Lodi, A., Tiziani, S., Khanim, F. L., Günther, U. L., Viant, M. R., Morgan, G. J., . . . Drayson, M. T. (2013). Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease. PloS one, 8(2), e56422. https://doi.org/10.1371/journal.pone.0056422

Chicago Style (17th ed.) Citation

Lodi, Alessia, Stefano Tiziani, Farhat L. Khanim, Ulrich L. Günther, Mark R. Viant, Gareth J. Morgan, Christopher M. Bunce, and Mark T. Drayson. "Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease." PloS One 8, no. 2 (2013): e56422. https://doi.org/10.1371/journal.pone.0056422.

MLA (9th ed.) Citation

Lodi, Alessia, et al. "Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease." PloS One, vol. 8, no. 2, 2013, p. e56422, https://doi.org/10.1371/journal.pone.0056422.